Literature DB >> 16762504

Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus.

Dong-Na Wu1, Dong-Sheng Pei, Qing Wang, Guang-Yi Zhang.   

Abstract

In this study, we examined the phosphorylation of ASK1, Akt and PTEN and the effects of sodium orthovanadate on these signal proteins during ischemia. Transient (15 min) brain ischemia was induced by the four-vessel occlusion in Sprague-Dawley rats. The following results were observed: (1) the decreased tyrosine phosphorylation of PTEN and the decreased serine phosphorylation of Akt induced by ischemia were suppressed by sodium orthovanadate, respectively. (2) The phosphorylation of ASK1 at serine 83 was decreased and the phosphorylation of ASK1 at threonine 845 was increased during ischemia. Sodium orthovanadate could alter the phosphorylation status of ASK1 at serine 83 and threonine 845 induced by ischemia. However, LY294002 could reverse the effect of sodium orthovanadate on the phosphorylation of ASK1 at threonine 845, namely, sodium orthovanadate inhibited ASK1 through the PI3-K/Akt-dependent pathway. Taken together, we concluded that sodium orthovanadate could increase the tyrosine posphorylation of PTEN and further inhibit the activation of ASK1 via activating Akt during cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762504     DOI: 10.1016/j.neulet.2006.05.018

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null Mice.

Authors:  Gang Xi; Victoria E Demambro; Susan D'Costa; Shalier K Xia; Zach C Cox; Clifford J Rosen; David R Clemmons
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

2.  Treatment with sodium orthovanadate reduces blood-brain barrier disruption via phosphatase and tensin homolog deleted on chromosome 10 (PTEN) phosphorylation in experimental subarachnoid hemorrhage.

Authors:  Yu Hasegawa; Hidenori Suzuki; Orhan Altay; Hank Chen; John H Zhang
Journal:  J Neurosci Res       Date:  2011-12-20       Impact factor: 4.164

3.  Correlation of NEDD4-1 and PTEN expression with the invasive capacity of pituitary adenomas.

Authors:  Jing Zhang; Xin Li; Yanyan Zhang
Journal:  Mol Clin Oncol       Date:  2016-11-24

Review 4.  PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?

Authors:  M M Mocanu; D M Yellon
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

5.  Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation.

Authors:  Shi Yue; Jianhua Rao; Jianjun Zhu; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Ling Lu; Xuehao Wang; Yuan Zhai
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

6.  S-nitrosylation of PTEN Invovled in ischemic brain injury in rat hippocampal CA1 region.

Authors:  Dong-Sheng Pei; Ya-Feng Sun; Yuan-Jian Song
Journal:  Neurochem Res       Date:  2009-03-06       Impact factor: 3.996

7.  AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells.

Authors:  Madhu A Lal; Dongsoon Bae; Tura C Camilli; Steven R Patierno; Susan Ceryak
Journal:  Cell Cycle       Date:  2009-05-25       Impact factor: 4.534

8.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

9.  Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: enhanced survival and mutagenesis.

Authors:  Dongsoon Bae; Tura C Camilli; Gina Chun; Madhu Lal; Kristen Wright; Travis J O'Brien; Steven R Patierno; Susan Ceryak
Journal:  Mutat Res       Date:  2008-10-21       Impact factor: 2.433

10.  PI3K/Akt Pathway Contributes to Neurovascular Unit Protection of Xiao-Xu-Ming Decoction against Focal Cerebral Ischemia and Reperfusion Injury in Rats.

Authors:  Rui Lan; Jun Xiang; Yong Zhang; Guo-Hua Wang; Jie Bao; Wen-Wei Li; Wen Zhang; Li-Li Xu; Ding-Fang Cai
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.